Diuretics	diuretics	O	O
,	,	O	O
potassium	potassium	S_chemical	O
and	and	O	O
arrhythmias	arrhythmias	O	S_disease
in	in	O	O
hypertensive	hypertensive	O	B_disease
coronary	coronary	O	B_disease
disease	disease	O	I_disease
.	.	O	O

It	it	O	O
has	has	O	O
been	been	O	O
proposed	proposed	O	O
that	that	O	O
modest	modest	O	O
changes	changes	O	O
in	in	O	O
plasma	plasma	O	O
potassium	potassium	S_chemical	O
can	can	O	O
alter	alter	O	O
the	the	O	O
tendency	tendency	O	O
towards	towards	O	O
cardiac	cardiac	O	B_disease
arrhythmias	arrhythmias	O	S_disease
.	.	O	O

If	if	O	O
this	this	O	O
were	were	O	O
so	so	O	O
,	,	O	O
patients	patients	O	O
with	with	O	O
coronary	coronary	O	B_disease
artery	artery	O	I_disease
disease	disease	O	I_disease
might	might	O	O
be	be	O	O
especially	especially	O	O
susceptible	susceptible	O	O
.	.	O	O

Thus	thus	O	O
,	,	O	O
myocardial	myocardial	O	B_disease
electrical	electrical	O	I_disease
excitability	excitability	O	I_disease
was	was	O	O
measured	measured	O	O
in	in	O	O
patients	patients	O	O
with	with	O	O
mild	mild	O	O
essential	essential	O	B_disease
hypertension	hypertension	O	S_disease
and	and	O	O
known	known	O	O
coronary	coronary	O	B_disease
artery	artery	O	I_disease
disease	disease	O	I_disease
after	after	O	O
8	8	O	O
weeks	weeks	O	O
of	of	O	O
treatment	treatment	O	O
with	with	O	O
a	a	O	O
potassium-conserving	potassium-conserving	B_chemical	O
diuretic	diuretic	I_chemical	O
(	(	O	O
amiloride	amiloride	S_chemical	O
)	)	O	O
and	and	O	O
a	a	O	O
similar	similar	O	O
period	period	O	O
on	on	O	O
a	a	O	O
potassium-losing	potassium-losing	B_chemical	O
diuretic	diuretic	I_chemical	O
(	(	O	O
chlorthalidone	chlorthalidone	O	O
)	)	O	O
in	in	O	O
a	a	O	O
randomised	randomised	O	O
study	study	O	O
.	.	O	O

Plasma	plasma	O	O
potassium	potassium	S_chemical	O
concentrations	concentrations	O	O
were	were	O	O
on	on	O	O
average	average	O	O
1	1	O	O
mmol/L	mmol/l	O	O
lower	lower	O	O
during	during	O	O
the	the	O	O
chlorthalidone	chlorthalidone	O	O
phase	phase	O	O
compared	compared	O	O
to	to	O	O
amiloride	amiloride	S_chemical	O
therapy	therapy	O	O
.	.	O	O

Blood	blood	O	O
pressure	pressure	O	O
and	and	O	O
volume	volume	O	O
states	states	O	O
as	as	O	O
assessed	assessed	O	O
by	by	O	O
bodyweight	bodyweight	O	O
,	,	O	O
plasma	plasma	O	O
renin	renin	O	O
and	and	O	O
noradrenaline	noradrenaline	S_chemical	O
(	(	O	O
norepinephrine	norepinephrine	S_chemical	O
)	)	O	O
concentrations	concentrations	O	O
were	were	O	O
similar	similar	O	O
on	on	O	O
the	the	O	O
2	2	O	O
regimens	regimens	O	O
.	.	O	O

Compared	compared	O	O
to	to	O	O
amiloride	amiloride	S_chemical	O
treatment	treatment	O	O
,	,	O	O
the	the	O	O
chlorthalidone	chlorthalidone	O	O
phase	phase	O	O
was	was	O	O
associated	associated	O	B_disease
with	with	O	I_disease
an	an	O	O
increased	increased	O	O
frequency	frequency	O	O
of	of	O	O
ventricular	ventricular	O	O
ectopic	ectopic	O	O
beats	beats	O	O
(	(	O	O
24-hour	24-hour	O	O
Holter	holter	O	O
monitoring	monitoring	O	O
)	)	O	O
and	and	O	O
a	a	O	O
higher	higher	O	O
Lown	lown	O	O
grading	grading	O	O
,	,	O	O
increased	increased	O	O
upslope	upslope	O	O
and	and	O	O
duration	duration	O	O
of	of	O	O
the	the	O	O
monophasic	monophasic	O	O
action	action	O	O
potential	potential	O	O
,	,	O	O
prolonged	prolonged	O	O
ventricular	ventricular	O	O
effective	effective	O	O
refractory	refractory	O	O
period	period	O	O
,	,	O	O
and	and	O	O
increased	increased	O	O
electrical	electrical	O	B_disease
instability	instability	O	I_disease
during	during	O	O
programmed	programmed	O	O
ventricular	ventricular	O	O
stimulation	stimulation	O	O
.	.	O	O

The	the	O	O
above	above	O	O
results	results	O	O
indicate	indicate	O	O
that	that	O	O
because	because	O	O
potassium-losing	potassium-losing	B_chemical	O
diuretic	diuretic	I_chemical	O
therapy	therapy	O	O
can	can	O	O
increase	increase	O	O
myocardial	myocardial	O	B_disease
electrical	electrical	O	I_disease
excitability	excitability	O	I_disease
in	in	O	O
patients	patients	O	O
with	with	O	O
ischaemic	ischaemic	O	B_disease
heart	heart	O	B_disease
disease	disease	O	I_disease
,	,	O	O
even	even	O	O
minor	minor	O	O
falls	falls	O	O
in	in	O	O
plasma	plasma	O	O
potassium	potassium	S_chemical	O
concentrations	concentrations	O	O
are	are	O	O
probably	probably	O	O
best	best	O	O
avoided	avoided	O	O
in	in	O	O
such	such	O	O
patients	patients	O	O
.	.	O	O

